Moderna's candidate, mRNA-1273, is already in late-stage human trials testing its ability to safely prevent infection
27 Aug 2020 5:55 AM GMT
The agreement calls for US to pay Sanofi and GlaxoSmithKline up to $2.1 billion to supply it with enough vaccines for 50...
1 Aug 2020 4:21 AM GMT